321 results on '"Lohaus F"'
Search Results
102. PV-0044: Repeat sbrt for pulmonary oligo-metastases
103. PV-0043: Histology as predictor for outcome following SBRT in NSCLC patients with lung oligo-metastases
104. Interobserver variability in the target delineation of hepatocellular carcinoma.
105. The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases
106. Patterns of care and outcome analysis of SBRT for colorectal lung and liver metastases in 388 patients with 500 metastases: an analysis of the DEGRO working group Stereotactic Radiotherapy
107. Interobserver variability in target volume delineation of hepatocellular carcinoma
108. Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes
109. SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
110. A comparative study of machine learning methods for time-To-event survival data for radiomics risk modelling
111. PO-0616: HPV, CSC marker expression and tumor hypoxia as prognosticators for LRC in patients with HNSCC
112. PO-0619: Comparison of a nanoString and RNA microarray gene signature predicting LRC after PORT-C in HNSCC
113. Impact of tumour hypoxia and cancer stem cells on loco-regional control after primary radiochemotherapy in locally advanced HNSCC – results of a multicentre biomarker study of the German Cancer Consortium radiation Oncology Group
114. Hypoxie und Krebsstammzellmarker als Biomarker für die Radio(chemo)therapie von Kopf-Hals Plattenepithelkarzinomen
115. Evaluation of a deformable registration algorithm for subsequent lung computed tomography imaging during radiochemotherapy
116. Biomarker für die individualisierte Strahlentherapie
117. Tumour volume, hypoxia and cancer stem cells as prognosticators for LRC after primary RCT in HNSCC
118. Gene signatures predict loco-regional control after postoperative radiochemotherapy in HNSCC
119. Impact of tumour hypoxia and cancer stem cells on loco-regional control after primary radiochemotherapy in locally advanced HNSCC : results of a multicentre biomarker study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
120. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
121. PO-0619: Comparison of a nanoString and RNA microarray gene signature predicting LRC after PORT-C in HNSCC
122. EP-1253: Interobserver variability in the target delineation of hepatocellular carcinoma
123. PO-0616: HPV, CSC marker expression and tumor hypoxia as prognosticators for LRC in patients with HNSCC
124. HPV and beyond—looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC
125. Identification of epigenetic prognosticators of adjuvant radiochemotherapy in HPV-negative squamous cell carcinomas of the head and neck (SCCHN) via genome-wide methylation analysis : A multicenter biomarker study of the German Cancer Consortium Radiation
126. Einfluss von Tumorvolumen und p16 Status auf die lokoregionäre Kontrolle von Kopf-Hals-Tumoren nach primärer Radiochemotherapie : Ergebnisse einer multizentrischen Biomarker-Studie des Deutschen Konsortiums für Translationale Krebsforschung (DKTK-ROG)
127. Einzelnukleotid Polymorphismen in Reparaturproteinen sind prognoserelevant für des Überleben von Kopf-Hals- Tumorpatienten nach postoperativer Radiochemotherapie mit Cisplatin (DKTK-ROG)
128. Next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck (LASCCHN) for assessment of mutational patterns and their interference with outcome after adjuvant chemoradiation : Results from a multicenter biomarker study of t
129. Cytotoxic Lymphocytes infiltrating tumor correlated with better Prognosis in HPV-Status-associated Patterns in Patients receiving chemotherapy adjuvant radio with Head and Neck Squamous
130. Interobserver Variability in the Target Volume Definition for Hepatocellular Carcinomas with and without portal vein Thrombosis
131. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicenter study of the German cancer consortium radiation oncology group (DKTK-ROG)
132. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
133. Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
134. Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG.
135. Influence of deformable Image Recording of PET/CT-Historical Data on Signal Values wihin a Contour: Deformation on Contours or Image Data Usage?
136. OC-0451: Tumour volume, hypoxia and cancer stem cells as prognosticators for LRC after primary RCT in HNSCC
137. OC-0582: Gene signatures predict loco-regional control after postoperative radiochemotherapy in HNSCC
138. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
139. HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
140. Mutational patterns of HPV+ and HPV- squamous cell carcinomas of the head and neck (SCCHN) and their interference with outcome after adjuvant chemoradiation: A multicenter biomarker study of the German Cancer Consortium Radiation Oncology Group
141. Interobservervariabilität bei der Zielvolumendefinition für hepatozelluläre Karzinome : Eine Analyse der Arbeitsgruppe „Stereotaktische Radiotherapie“ der Deutschen Gesellschaft für Radioonkologie (DEGRO).
142. SBRT for Lung Metastases: A Pooled Analysis of 651 Patients and 868 Lesions of the German Working Group Stereotactic Radiotherapy
143. Radiomic models for validation in patients with locally advanced HNSCC treated with primary RTCx
144. Tumor Volume, HPV Status, and Cancer Stem Cell Marker Expression as prognostic Markers for the locoregional Tumor Control in Patients with locally advanced Head and Neck Squamous Cell Carcinoma after primary Chemoradiotherapy
145. PD-0064 Metastases-directed SRT combined with systemic therapy: 2y results of the TOaSTT real-world database.
146. Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy.
147. PO-1304 Impact of blood parameters and normal tissue dose on overall survival in esophageal cancer patients.
148. OC-0256 Biomarker development from joint analyses of HNSCC xenografts and patients treated by PORT-C.
149. MO-0139 PORT-C improves LRC in a subset of patients with intermediate-risk HNSCC: A matched pair analysis.
150. PO-1332 OLI-P trial: pattern of progression after radiotherapy in PSMA-PET positive METs of prostate cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.